Therapy of lower respiratory tract infections with moxalactam.

Moxalactam was evaluated in the therapy of lower respiratory tract infections in 40 patients. The most common organisms isolated were Streptococcus pneumoniae (37.2%) and Haemophilus influenzae (21.5%). Gram-negative enteric organisms were isolated from six patients. No patient was evaluated as a tr...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Εκδόθηκε σε:	Antimicrob Agents Chemother
Κύριοι συγγραφείς:	Lentino, J R, Rytel, M W, Moore, E
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	American Society for Microbiology (ASM) 1981
Θέματα:	Research Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181526/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6457557/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.5.801
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!